Download
https://www.ndtvprofit.com/business/astrazeneca-to-buy-fusion-pharma-for-up-to-2-4-billion?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Shares of Astra were little changed in early London trading on Tuesday. They are down around 5% over the last 12 months.
Share